Extranodal NK- and T-cell lymphoma nasal type · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
SMILE Variant #01 Partial | — | R 11 718 | 21d | — | — | ~6 | ~R 70 309 indirect | — |
L-Asparaginase, Vincristine, Prednisolone Variant #02 | — | R 1 416 | 28d | — | — | ~1 | ~R 1 416 indirect | — |
L-Asparaginase, Vincristine, Dexamethasone Variant #02 Partial | — | R 934 | 28d | — | — | ~6 | ~R 5 605 indirect | — |
3 of 3 regimens shown